about
What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease.Tumor suppressor NF2/Merlin is a microtubule stabilizer.Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression.67-kDa laminin receptor-dependent protein phosphatase 2A (PP2A) activation elicits melanoma-specific antitumor activity overcoming drug resistance.Alcohol interacts with genetic alteration of the Hippo tumor suppressor pathway to modulate tissue growth in DrosophilaRole of Merlin/NF2 inactivation in tumor biology.AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by MerlinLoss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling.FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Functional interdependence of NHE1 and merlin in human melanoma cells.Merlin sumoylation is required for its tumor suppressor activity.The role of the hippo pathway in melanocytes and melanoma.Single cell polarity in liquid phase facilitates tumour metastasis.Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
P2860
Q30429628-F0DCA4E6-2F0A-46A0-A035-469AEE734967Q30572320-C00326D8-3E52-449F-A823-2C2B1211F788Q33978086-3BECA1AB-D442-4648-98FC-9CCED38A6487Q34379050-3B4BC56B-176D-4D93-A690-C32157CD7244Q34552639-3D79A5E3-1217-4C3B-ADDB-30931599377BQ35036796-68F74990-D996-476E-A115-5BA40C7A2A6AQ36189820-E5642F40-5E16-47BF-9295-5040602780FAQ36527910-48E4D7F1-E9E8-46B4-9419-C4217FAC81BCQ37599488-F7D9E01F-C938-49C4-A413-C68B1C995D0DQ37688487-7FC83AFB-6459-4765-8A71-FA5ED95DE2DEQ38722193-D7E64775-11A4-41CE-940E-91AE33F35B29Q38951241-5F829D4D-7411-424C-9F4C-168858FEB26DQ39069340-C5CDE33D-1D2D-400F-BE4F-D16199C1F396Q40748577-D0F1565E-B16A-456B-9EF3-F1F38C826717Q50868185-A74F9340-AC47-413A-A6B9-A4E1617A5A4FQ55234046-B3498799-9FD4-478D-9288-A32748E9430A
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Merlin is a negative regulator of human melanoma growth
@ast
Merlin is a negative regulator of human melanoma growth
@en
Merlin is a negative regulator of human melanoma growth
@nl
type
label
Merlin is a negative regulator of human melanoma growth
@ast
Merlin is a negative regulator of human melanoma growth
@en
Merlin is a negative regulator of human melanoma growth
@nl
prefLabel
Merlin is a negative regulator of human melanoma growth
@ast
Merlin is a negative regulator of human melanoma growth
@en
Merlin is a negative regulator of human melanoma growth
@nl
P2093
P2860
P1433
P1476
Merlin is a negative regulator of human melanoma growth
@en
P2093
Lucas B Murray
Ying-Ka Ingar Lau
P2860
P304
P356
10.1371/JOURNAL.PONE.0043295
P407
P577
2012-08-17T00:00:00Z